首页> 外国专利> Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow

Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow

机译:减少因冠状动脉血流丢失,减少或中断而引起的心肌损害和心律不齐的发生

摘要

A method and composition is disclosed for reducing the extent of cardiac arrhythmias, both resulting from loss, decrease or interruption to the blood supply such as may happen during a heart attack or during cardiac surgery, in mammals. In particular, the present invention relates to a method of limiting or preventing cardiac cell damage and/or death, and limiting or preventing lethal or non-lethal cardiac arrhythmias, in a human, by administering to the cardiac cells a compound which selectively blocks or partially blocks persistent sodium currents and/or persistent sodium channels of cardiac cells. The composition involves any physiologically acceptable chemical or pharmaceutical composition comprising as its active ingredient a cardiac persistent sodium current and/or persistent sodium channel blocker.
机译:公开了一种用于减少心脏心律不齐的程度的方法和组合物,两者均是由于血液供应的丢失,减少或中断而导致的,例如在心脏病发作或心脏手术期间可能发生的血液供应的减少,减少或中断。特别地,本发明涉及通过对心脏细胞施用选择性阻断或预防心脏细胞损伤和/或死亡,以及限制或预防人的致命性或非致命性心律不齐的方法。部分阻断持久性钠电流和/或心肌细胞的持久性钠通道。该组合物包括任何生理可接受的化学或药物组合物,其包含心脏持久钠电流和/或持久钠通道阻滞剂作为其活性成分。

著录项

  • 公开/公告号AU2006284513B2

    专利类型

  • 公开/公告日2013-09-05

    原文格式PDF

  • 申请/专利权人 STEVEN WEISS;

    申请/专利号AU20060284513

  • 发明设计人 WEISS STEVEN MICHAEL;

    申请日2006-08-24

  • 分类号A61P9/06;A61K31/136;A61K31/167;A61K31/198;A61K31/423;A61K31/428;A61K31/58;

  • 国家 AU

  • 入库时间 2022-08-21 16:37:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号